A novel experimental model of cervical spondylotic myelopathy (CSM) to facilitate translational research

Neurobiology of Disease

Volumn 54, Issue , 2013, Pages 43-58

  Karadimas, Spyridon K ^a,b   Moon, Eun Su ^b   Yu, Wen Ru ^b   Satkunendrarajah, Kajana ^b   Kallitsis, Joannis K ^c   Gatzounis, Georgios ^c   Fehlings, Michael G ^a,b,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF PATRAS   (Greece)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cervical spondylotic myelopathy; Chronic cervical spinal cord compression; CSM; Nontraumatic cervical spinal cord injury

Indexed keywords

PROTEIN BAD; PROTEIN BAX; PROTEIN BCL XL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR HORN CELL DISEASE; APOPTOSIS; ARTICLE; ASTROCYTOSIS; ATAXIA; CENTRAL NERVOUS SYSTEM DISEASE; CERVICAL SPONDYLOTIC MYELOPATHY; CONTROLLED STUDY; FEMALE; GAIT DISORDER; GRAY MATTER LOSS; HOFFMANN REFLEX; INTRACELLULAR SIGNALING; LAMINECTOMY; LIMB WEAKNESS; NERVE DEGENERATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGENERATIVE MEDICINE; SENSORY DYSFUNCTION; SPASTIC GAIT; SPASTICITY; SPINAL CORD COMPRESSION; SPINAL CORD DECOMPRESSION; WHITE MATTER LOSS;

ANIMALS; BLOTTING, WESTERN; CERVICAL VERTEBRAE; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD COMPRESSION; SPINAL CORD DISEASES; SPONDYLOSIS; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84875333402     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2013.02.013     Document Type: Article

References (44)

1. Baptiste D.C., Fehlings M.G. Pathophysiology of cervical myelopathy. Spine J. 2006, 6:190S-197S.
2. Baron E.M., Young W.F. Cervical spondylotic myelopathy: a brief review of its pathophysiology, clinical course, and diagnosis. Neurosurgery 2007, 60:S35-S41.
3. Beattie M.S., Manley G.T. Tight squeeze, slow burn: inflammation and the aetiology of cervical myelopathy. Brain. 2011, 134:1259-1261.
4. Echeverry S., et al. Peripheral nerve injury alters blood-spinal cord barrier functional and molecular integrity through a selective inflammatory pathway. J. Neurosci. 2011, 31:10819-10828.
5. Emery S.E. Cervical spondylotic myelopathy: diagnosis and treatment. J. Am. Acad. Orthop. Surg. 2001, 9:376-388.
6. Fehlings M.G., Skaf G. A review of the pathophysiology of cervical spondylotic myelopathy with insights for potential novel mechanisms drawn from traumatic spinal cord injury. Spine (Phila Pa 1976) 1998, 23:2730-2737.
7. Fehlings M.G., Tator C.H. The relationships among the severity of spinal cord injury, residual neurological function, axon counts, and counts of retrogradely labeled neurons after experimental spinal cord injury. Exp. Neurol. 1995, 132:220-228.
8. Fehlings M.G., et al. Perioperative and delayed complications associated with the surgical treatment of cervical spondylotic myelopathy based on 302 patients from the AOSpine North America Cervical Spondylotic Myelopathy Study. J. Neurosurg. Spine. 2012, 16:425-432.
9. Ferguson R.J., Caplan L.R. Cervical spondylitic myelopathy. Neurol. Clin. 1985, 3:373-382.
10. Fernandez de Rota J.J., et al. Cervical spondylotic myelopathy due to chronic compression: the role of signal intensity changes in magnetic resonance images. J. Neurosurg. Spine 2007, 6:17-22.
11. Firooznia H., et al. Sudden quadriplegia after a minor trauma. The role of preexisting spinal stenosis. Surg. Neurol. 1985, 23:165-168.
12. Gensel J.C., et al. Behavioral and histological characterization of unilateral cervical spinal cord contusion injury in rats. J. Neurotrauma 2006, 23:36-54.
13. Gooding M.R. Pathogenesis of myelopathy in cervical spondylosis. Lancet 1974, 2:1180-1181.
14. Gorter K. Influence of laminectomy on the course of cervical myelopathy. Acta Neurochir. (Wien) 1976, 33:265-281.
15. Guest J.D., et al. Xenografts of expanded primate olfactory ensheathing glia support transient behavioral recovery that is independent of serotonergic or corticospinal axonal regeneration in nude rats following spinal cord transection. Exp. Neurol. 2008, 212:261-274.
16. Hamers F.P., et al. CatWalk-assisted gait analysis in the assessment of spinal cord injury. J. Neurotrauma 2006, 23:537-548.
17. Karadimas S.K., et al. The role of oligodendrocytes in the molecular pathobiology and potential molecular treatment of cervical spondylotic myelopathy. Curr. Med. Chem. 2010, 17:1048-1058.
18. Karimi-Abdolrezaee S., et al. Synergistic effects of transplanted adult neural stem/progenitor cells, chondroitinase, and growth factors promote functional repair and plasticity of the chronically injured spinal cord. J. Neurosci. 2010, 30:1657-1676.
19. Klironomos G., et al. New experimental rabbit animal model for cervical spondylotic myelopathy. Spinal Cord. 2011, 49:1097-1102.
20. Koopmans G.C., et al. The assessment of locomotor function in spinal cord injured rats: the importance of objective analysis of coordination. J. Neurotrauma 2005, 22:214-225.
21. Kuhtz-Buschbeck J.P., et al. Analysis of gait in cervical myelopathy. Gait Posture 1999, 9:184-189.
22. Lee J.K., et al. Effect of spinal cord injury severity on alterations of the H-reflex. Exp. Neurol. 2005, 196:430-440.
23. Lee H.J., et al. Better functional outcome of compression spinal cord injury in mice is associated with enhanced H-reflex responses. Exp. Neurol. 2009, 216:365-374.
24. Lee J., et al. Development and characterization of a novel rat model of cervical spondylotic myelopathy: the impact of chronic cord compression on clinical, neuroanatomical, and neurophysiological outcomes. J. Neurotrauma. 2012, 29:1012-1027.
25. Lunsford L.D., et al. Anterior surgery for cervical disc disease. Part 2: treatment of cervical spondylotic myelopathy in 32 cases. J. Neurosurg. 1980, 53:12-19.
26. Maezawa Y., et al. Gait analysis of spastic walking in patients with cervical compressive myelopathy. J. Orthop. Sci. 2001, 6:378-384.
27. Mattei T.A., Goulart C.R., Milano J.B., Dutra L.P., Fasset D.R. Cervical spondylotic myelopathy: pathophysiology, diagnosis, and surgical techniques. ISRN Neurol. 2011, 2011:463729. http://dx.doi.org/10.5402/2011/463729 (Epub 2011 Sep 28).
28. McCormack B.M., Weinstein P.R. Cervical spondylosis. An update. West. J. Med. 1996, 165:43-51.
29. McCormick W.E., et al. Cervical spondylotic myelopathy: make the difficult diagnosis, then refer for surgery. Cleve. Clin. J. Med. 2003, 70:899-904.
30. Moore A.P., Blumhardt L.D. A prospective survey of the causes of non-traumatic spastic paraparesis and tetraparesis in 585 patients. Spinal Cord 1997, 35:361-367.
31. Morio Y., et al. Correlation between operative outcomes of cervical compression myelopathy and MRI of the spinal cord. Spine 2001, 26:1238-1245.
32. Okamoto N., et al. H-reflex of the upper extremities in cervical myelopathy. Int. Orthop. 1980, 4:193-203.
33. Suzuki E., et al. Analysis of the spastic gait caused by cervical compression myelopathy. J. Spinal Disord. Tech. 2002, 15:519-522.
34. Swagerty D.L. Cervical spondylotic myelopathy: a cause of gait disturbance and falls in the elderly. Kans. Med. 1994, 95(226-7):229.
35. Takenouchi T., et al. Expression of apoptosis signal-regulating kinase 1 in mouse spinal cord under chronic mechanical compression: possible involvement of the stress-activated mitogen-activated protein kinase pathways in spinal cord cell apoptosis. Spine (Phila Pa 1976) 2008, 33:1943-1950.
36. Taylor A.R. Vascular factors in the myelopathy associated with cervical spondylosis. Neurology 1964, 14:62-68.
37. van Middendorp J.J., et al. Diagnostic criteria of traumatic central cord syndrome. Part 2: a questionnaire survey among spine specialists. Spinal Cord 2010, 48:657-663.
38. Wilson C.B., et al. Experimental cervical myelopathy. II. Acute ischemic myelopathy. Arch. Neurol. 1969, 21:571-589.
39. Yamaura I., et al. Mechanism of destructive pathologic changes in the spinal cord under chronic mechanical compression. Spine (Phila Pa 1976) 2002, 27:21-26.
40. Young W.F. Cervical spondylotic myelopathy: a common cause of spinal cord dysfunction in older persons. Am. Fam. Physician 2000, 62(1064-70):1073.
41. Yu Y.L., et al. Cervical myelopathy due to ossification of the posterior longitudinal ligament. A clinical, radiological and evoked potentials study in six Chinese patients. Brain 1988, 111(Pt 4):769-783.
42. Yu W.R., et al. Molecular mechanisms of spinal cord dysfunction and cell death in the spinal hyperostotic mouse: implications for the pathophysiology of human cervical spondylotic myelopathy. Neurobiol. Dis. 2009, 33:149-163.
43. Yu W.R., et al. Human neuropathological and animal model evidence supporting a role for Fas-mediated apoptosis and inflammation in cervical spondylotic myelopathy. Brain. 2011, 134:1277-1292.
44. Yue W.M., et al. The Torg-Pavlov ratio in cervical spondylotic myelopathy: a comparative study between patients with cervical spondylotic myelopathy and a nonspondylotic, nonmyelopathic population. Spine (Phila Pa 1976) 2001, 26:1760-1764.